About this trial
This study involves a type of robotic surgery called telesurgery, where a highly trained surgeon performs the surgical procedure using a secure internet connection to operate on a patient in a different location. Urologists from The goal of this study is to find out how safe and effective telesurgery is when used in real hospitals. The study aims to understand how well Telesurgery works in different settings, what technical challenges might come up (like internet speed or delays), and how it can be used to train new surgeons.
Eligibility criteria
Qualifiers
Age 18 - 90
Male or female
Localized Prostate Cancer (ICD-10: C61), appropriate for robotic radical prostatectomy.
Primary diagnosis of urinary system disease and prostate disorders (C61 and N40.1) scheduled to undergo treatment with robotic surgery. These patients don't have access to robotic surgery in their routine and the study will give them the opportunity to have advanced technology and the gold-standard treatment with experts in the field.
Disqualifiers
Uncontrolled cardiovascular, pulmonary, or metabolic disease.
Severe anesthetic risk classified as ASA Class IV or higher.
Patients enrolled in another interventional research study that may interfere with surgical safety or outcomes.
Patients unwilling or unable to comply with the perioperative and follow-up schedule.
Trial design
Treatments tested in this trial
- Telesurgery utilizing Microport Medbot Robotic Platform